EE666 Cost-Analysis of the Introduction of a Second Generation Biomarker Breast Cancer Prognostic Test for the Management of Early Breast Cancer in Greece
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.905
https://www.valueinhealthjournal.com/article/S1098-3015(22)03109-6/fulltext
Title :
EE666 Cost-Analysis of the Introduction of a Second Generation Biomarker Breast Cancer Prognostic Test for the Management of Early Breast Cancer in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03109-6&doi=10.1016/j.jval.2022.09.905
First page :
Section Title :
Open access? :
No
Section Order :
10447